Kobo Biotech Key Ratios
BSE: 531541
₹5.72
₹0.11
(1.96%)
As on 27-Aug-2026IST
Market cap
₹14 Cr
Revenue (TTM)
₹-- Cr
P/E Ratio
--
P/B Ratio
-0.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -7.72 | -9.02 | 5.09 | 11.08 | 7.75 |
| Net Profit | -5.81 | -8.40 | 5.27 | 18.63 | 12.31 |
| EPS | -5.80 | -8.39 | 5.27 | 18.63 | 12.31 |
| Book Value | -- | -- | -3.93 | -4.48 | -15.54 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Capital
| -71.75 | -47.63 | -125.54 | -52.88 | -36.84 |
| Return on Assets
| -7.07 | -7.86 | -7.32 | -6.72 | -7.19 |
| Debt to Equity (x)
| -- | -- | -1.01 | -1.05 | -1.09 |
Profitability
ROCE
-125.54
Lower than Peers by 141.99
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-125.54
|
-52.88
|
-36.84
|
-17.59
|
-5.31
|
|
Peer Median
|
16.46
|
15.49
|
17.37
|
17.62
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
13.87
|
14.72
|
15.70
|
18.36
|
--
|
ROA
-7.32
Lower than Peers by 15.35
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-7.32
|
-6.72
|
-7.19
|
-9.83
|
-8.24
|
|
Peer Median
|
8.04
|
7.19
|
9.43
|
9.43
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
10.05
|
10.28
|
13.90
|
17.27
|
--
|
Net Margin
-6,881.32
Lower than Peers by 6,890.43
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-6,881.32
|
-32,426.32
|
-36,535.53
|
-11.42
|
-53,569.08
|
|
Peer Median
|
9.11
|
6.78
|
10.91
|
12.99
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.17
|
10.56
|
12.63
|
15.47
|
--
|
EBIT Growth
-7.32
Lower than Peers by 19.37
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-7.32
|
11.22
|
96.25
|
-1,661.97
|
0.70
|
|
Peer Median
|
12.05
|
6.17
|
-2.90
|
51.73
|
--
|
Net Profit Growth
-6.11
Lower than Peers by 28.26
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-6.11
|
11.25
|
63.53
|
20.83
|
8.45
|
|
Peer Median
|
22.15
|
27.97
|
-14.10
|
44.15
|
--
|
EPS Growth
-6.11
Lower than Peers by 14.91
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-6.11
|
11.24
|
63.53
|
20.83
|
8.45
|
|
Peer Median
|
8.80
|
--
|
-3.68
|
38.52
|
--
|
Book Value Growth
-3.93
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-3.93
|
-3.85
|
-4.54
|
-14.20
|
-21.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-1.01
Lower than Peers by 1.05
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-1.01
|
-1.05
|
-1.09
|
-1.15
|
-2.43
|
|
Peer Median
|
0.03
|
0.05
|
0.14
|
0.23
|
--
|
Short term debt to equity ratio
-0.43
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-0.43
|
-0.45
|
-0.47
|
-0.49
|
-1.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.24
Lower than Peers by 1.96
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
0.24
|
0.23
|
0.23
|
0.23
|
0.53
|
|
Peer Median
|
2.20
|
1.93
|
1.82
|
1.75
|
--
|
Quick Ratio
0.14
Lower than Peers by 1.58
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
0.14
|
0.12
|
0.12
|
0.12
|
0.35
|
|
Peer Median
|
1.72
|
1.59
|
1.30
|
1.04
|
--
|
Interest Coverage
-52,297.00
Lower than Peers by 52,309.28
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-52,297.00
|
-49,287.00
|
-27,766.00
|
-111.95
|
-0.77
|
|
Peer Median
|
12.28
|
12.45
|
16.98
|
15.07
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
26.23
|
23.97
|
24.57
|
20.26
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.74
|
0.88
|
0.82
|
0.79
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-1.44
Lower than Peers by 40.60
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-1.44
|
-1.84
|
-0.82
|
--
|
--
|
|
Peer Median
|
39.17
|
40.74
|
25.97
|
33.71
|
--
|
Price / Book Value
-0.05
Lower than Peers by 3.66
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-0.05
|
-0.07
|
-0.04
|
-0.11
|
-0.16
|
|
Peer Median
|
3.61
|
3.87
|
2.79
|
4.36
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.19
|
0.20
|
0.65
|
0.28
|
--
|
EV/EBITDA
-123.32
Lower than Peers by 152.11
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
-123.32
|
-173.29
|
-97.37
|
-14.66
|
-100.45
|
|
Peer Median
|
28.79
|
25.41
|
15.07
|
23.32
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Kobo Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3,944
|
2,959
|
3,742
|
6,050
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
